Literature DB >> 7974104

National survey on laparoscopic cholecystectomy in Spain. Results of a multiinstitutional study conducted by the Committee for Endoscopic Surgery (Associación Española de Cirujanos).

E Vincent-Hamelin1, A C Pallares, J A Felipe, E L Roselló, J A Caperochipi, J L Cantero, F D Gomis, F F Corvinos, S P Sanchez, J P Lesquereux.   

Abstract

We present a joint study conducted by the Committee for Endoscopic Surgery in Spain. Sixty-nine surgeons reported 2,342 laparoscopic cholecystectomies (LCs) performed until November 1992. The conversion rate was 5.1%. The overall morbidity was 7.1%. The biliary morbidity was 0.45%: Seven severe bile duct injuries were recognized at laparoscopy (0.28%) and four lesions were postoperatively diagnosed (0.16%). Bile leak unrelated to bile duct lesion occurred in 14 patients (0.7%), leading to five reoperations. The mortality was 0.12% and was unrelated to the laparoscopic approach in two cases. The risk factors for biliary complications were obesity, previous history of jaundice, and previous hospital admissions. Surgeon experience was defined by 50 LCs performed and the overall complication rate presented a statistically significant relation to surgeon experience (P < 0.001).

Entities:  

Mesh:

Year:  1994        PMID: 7974104     DOI: 10.1007/BF00593438

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  18 in total

1.  Laparoscopic injuries to the bile duct. A cause for concern.

Authors:  A R Moossa; D W Easter; E Van Sonnenberg; G Casola; H D'Agostino
Journal:  Ann Surg       Date:  1992-03       Impact factor: 12.969

2.  Open laparoscopy vs. closed laparoscopy: a comparison of complication rates.

Authors:  H M Hasson
Journal:  Adv Plan Parent       Date:  1978

3.  Coelioscopic cholecystectomy. Preliminary report of 36 cases.

Authors:  F Dubois; P Icard; G Berthelot; H Levard
Journal:  Ann Surg       Date:  1990-01       Impact factor: 12.969

4.  Bile duct complications after laparoscopic cholecystectomy.

Authors:  D B Adams; M R Borowicz; F T Wootton; J T Cunningham
Journal:  Surg Endosc       Date:  1993 Mar-Apr       Impact factor: 4.584

5.  Preoperative ERCP and intraoperative cholangiography in the age of laparoscopic cholecystectomy.

Authors:  G Berci
Journal:  Surg Endosc       Date:  1993 Jan-Feb       Impact factor: 4.584

Review 6.  Cholecystectomy: the gold standard.

Authors:  C K McSherry
Journal:  Am J Surg       Date:  1989-09       Impact factor: 2.565

Review 7.  Pulmonary embolism following laparoscopic cholecystectomy: report of two cases and review of the literature.

Authors:  J Mayol; E Vincent-Hamelin; J M Sarmiento; E O Oshiro; J Diaz-Gonzalez; F J Tamayo; J A Fernándeź-Represa
Journal:  Surg Endosc       Date:  1994-03       Impact factor: 4.584

8.  Laparoscopic cholecystectomy in the obese patient.

Authors:  D Collet; M Edye; E Magne; J Perissat
Journal:  Surg Endosc       Date:  1992 Jul-Aug       Impact factor: 4.584

9.  Multipractice analysis of laparoscopic cholecystectomy in 1,983 patients.

Authors:  G M Larson; G C Vitale; J Casey; J S Evans; G Gilliam; L Heuser; G McGee; M Rao; M J Scherm; C R Voyles
Journal:  Am J Surg       Date:  1992-02       Impact factor: 2.565

10.  Laparoscopic cholecystectomy: the state of the art. A report on 700 consecutive cases.

Authors:  J Périssat; D Collet; R Belliard; J Desplantez; E Magne
Journal:  World J Surg       Date:  1992 Nov-Dec       Impact factor: 3.352

View more
  2 in total

Review 1.  The E.A.E.S. Consensus Development Conferences on laparoscopic cholecystectomy, appendectomy, and hernia repair. Consensus statements--September 1994. The Educational Committee of the European Association for Endoscopic Surgery.

Authors:  E Neugebauer; H Troidl; C K Kum; E Eypasch; M Miserez; A Paul
Journal:  Surg Endosc       Date:  1995-05       Impact factor: 4.584

Review 2.  Endocrine and metabolic response to gastric bypass.

Authors:  Jabbar Saliba; Julia Wattacheril; Naji N Abumrad
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2009-09       Impact factor: 4.294

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.